Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$509.48 +0.04 (+0.01%)
As of: Sep 30, 2026 · 12:17 PM EDT

Madrigal Pharmaceuticals (MDGL) EV to CFO (2016)

Updated

Madrigal Pharmaceuticals' (MDGL) EV to CFO came in at 40.22 for Q2 2016, down 46.8% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) EV to CFO (2016) Analysis & Trends

For the trailing twelve months through Jun 30, 2016, EV to CFO at Madrigal Pharmaceuticals was 37.42.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Madrigal Pharmaceuticals 15.07 Bn 11.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 40.22
Mar 31, 2016 75.53
API Access

Madrigal Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=MDGL&period=max&api_key=YOUR_API_KEY